Jeffrey M. Lafond

Jeffrey Lafond practices at Trident Ambulatory Surgery - HOPD in Charleston, South Carolina.

Jeffrey Lafond's NPI, 1245243500, was assigned on August 15, 2006. Jeffrey Lafond graduated from Medical University of South Carolina (MUSC) in 1990. Jeffrey Lafond's South Carolina license number on file is 15693.

Jeffrey Lafond's primary practice is Trident Ambulatory Surgery - HOPD, at 9313 Medical Plaza Dr, Charleston, SC 29406.

Jeffrey Lafond's primary practice is Trident Ambulatory Surgery - HOPD in Charleston, South Carolina. Jeffrey Lafond is also affiliated with HCA Healthcare Trident Hospital. The medical group on file is HCA Healthcare Trident Surgical Specialists. Dmand AI also links Jeffrey Lafond to 1 more hospital, 1 physician office, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jeffrey Lafond practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Jeffrey Lafond's primary specialty in the NPI Registry, under taxonomy code 208600000X. Jeffrey Lafond is board certified in surgery by the American Board of Surgery. Jeffrey Lafond has a license on file in South Carolina.

Dmand AI lists abdominal adhesion surgery, abdominal hernia repair surgery, acute gallbladder or bile duct inflammation, amputation, appendectomy, bladder removal, blood vessel access for dialysis and colon removal among the conditions Jeffrey Lafond treats.

CMS data shows 323 Medicare services from Jeffrey Lafond across 7 procedure codes in 2024, for 250 Medicare patients. Medicare paid $53,109 for them.

CMS counts 250 Medicare patients who saw Jeffrey Lafond in 2024. The largest group is 75 to 84, with 103 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jeffrey Lafond's median patient age at 59, with 51% women.

In 2024, Jeffrey Lafond wrote 221 Medicare Part D claims for 117 patients. 98% of them were for generic drugs. CMS names the drug for 179 of them, across 3 drugs with 11 or more claims each, at $740 in total drug cost. In 2023, CMS named 267 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Jeffrey Lafond for performance year 2024, reported individually. Jeffrey Lafond accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 35 procedures of hernia repair - groin (open) by Jeffrey Lafond, more than 99% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Jeffrey Lafond in 2011. Jeffrey Lafond's most frequent co-authors are Marie Leslie Borum, MD and Amy E. Doran, MD.

CMS Open Payments shows 100 general payments to Jeffrey Lafond from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Smith & Nephew, Inc. paid the most, $351.

Dmand AI lists 2 awards for Jeffrey Lafond, most recently CMS Stage 1 EHR in 2014.

Jeffrey Lafond graduated from Medical University of South Carolina (MUSC) in 1990. Jeffrey Lafond is a member of ACS.

Jeffrey Lafond is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.